The Dual Role of the NFATc2/galectin‐9 Axis in Modulating Tumor‐Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma
Open Access
- 25 March 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (20) , 2306059
Abstract
Tumor‐initiating cells (TICs) resilience and an immunosuppressive microenvironment are aggressive oncogenic phenotypes that contribute to unsatisfactory long‐term outcomes in lung adenocarcinoma (LUAD) patients. The molecular mechanisms mediating the interaction between TICs and immune tolerance have not been elucidated. The role of Galectin‐9 in oncogenesis and immunosuppressive microenvironment is still unknown. This study explored the potential role of galectin‐9 in TIC regulation and immune modulation in LUAD. The results show that galectin‐9 supports TIC properties in LUAD. Co‐culture of patient‐derived organoids and matched peripheral blood mononuclear cells showed that tumor‐secreted galectin‐9 suppressed T cell cytotoxicity and induced regulatory T cells (Tregs). Clinically, galectin‐9 is upregulated in human LUAD. High expression of galectin‐9 predicted poor recurrence‐free survival and correlated with high levels of Treg infiltration. LGALS9 , the gene encoding galectin‐9, is found to be transcriptionally regulated by the nuclear factor of activated T cells 2 (NFATc2), a previously reported TIC regulator, via in silico prediction and luciferase reporter assays. Overall, the results suggest that the NFATc2/galectin‐9 axis plays a dual role in TIC regulation and immune suppression.Keywords
This publication has 52 references indexed in Scilit:
- Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular MatrixACS Chemical Biology, 2022
- Tumor organoids: Opportunities and challenges to guide precision medicineCancer Cell, 2021
- Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancerBiochemical and Biophysical Research Communications, 2018
- Sox2 Communicates with Tregs Through CCL1 to Promote the Stemness Property of Breast Cancer CellsStem Cells, 2017
- A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic ProgressionCell Stem Cell, 2015
- The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T CellsImmunity, 2015
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T CellsImmunity, 2014
- Evolution of the Cancer Stem Cell ModelCell Stem Cell, 2014
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assaysJournal of Immunological Methods, 2009
- CD4+CD25+ regulatory T cells in patients with gastrointestinal malignanciesCancer, 2003